Researchers showed that LGP2 binds viral RNA ends and recruits MDA5 molecules to form filament clusters that activate ...

九州大学は、極限環境がリボ核酸(RNA)の前生物化学に与える影響を調査し、「アデノシン一リン酸」(AMP)がRNA鎖へ繋がる重合反応を起こす証拠は発見できず、逆に多様な有機化合物へ分解・再編成されることを発見したと発表した。

In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions ...

Spinoff from Novartis AG's acquisition of Avidity Biosciences advances precision cardiology programs using targeted RNA delivery platform Lead candidates ATR 1072 ...

European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...

Four months after Avidity’s $11.4 billion buyout, Atrium debuted with $270 million in cash and plans to pick up its ...

How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.

Alpha-1 Antitrypsin Deficiency (AATD) is a rare genetic disorder caused by SERPINA1 gene mutations, leading to conditions like pulmonary emphysema and liver dysfunction. The AATD market is in its ...

The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in ...

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

Published as an arXiv preprint, the paper details how unsupervised and self-supervised AI models are matching or surpassing supervised systems while uncovering biological patterns that traditional ...

Curtis Millen, Executive Vice President and Chief Financial Officer of BCE Inc. will participate in a fireside chat at the 29th Annual Scotiabank Telecom, Media & Technology Conference in Toronto, on ...